Austin Chin Chwan Ng1, Jerrett K Lau2, Vincent Chow2, Dona Adikari2, David Brieger2, Leonard Kritharides2. 1. Department of Cardiology, Concord Hospital, The University of Sydney, 1 Hospital Road, Concord 2139, NSW, Australia. Electronic address: chin.ng@sydney.edu.au. 2. Department of Cardiology, Concord Hospital, The University of Sydney, 1 Hospital Road, Concord 2139, NSW, Australia.
Abstract
BACKGROUND: Temporary-transvenous-cardiac-pacing (TTCP) is a potentially lifesaving procedure, however trends in its utilization and outcomes in unselected contemporary populations are all unknown. METHODS: Consecutive patients requiring TTCP between July-1, 2000 and December-31, 2013 were identified from a statewide registry of admitted patients. In addition, all patients who underwent other cardiac procedures including permanent-pacemaker (PPM) implantation, automated-implantable-cardiac-defibrillator (AICD) implantation, percutaneous-coronary-intervention (PCI), or coronary-artery-bypass-graft (CABG) surgery were identified for comparative outcome analyses. Survival was tracked from a statewide death registry. RESULTS: A total of 4838 patients (mean age [±standard deviation] 74.7 ± 12.7 years; 58.0% males) requiring TTCP were identified. The incidence for TTCP was 5.86 ± 1.06 cases per-100,000-persons-per-annum, declining by 46% between 2003 and 2013. During 4.2 ± 3.7 years of follow-up, 2594 (53.6%) patients died, of whom 569 (11.8%) died during the index admission. Weekend admission was associated with increased mortality compared to weekdays (hazard ratio: 1.15, 95% confidence interval [CI] 1.06-1.26, p = 0.002) and independently predicted all-cause death. After adjusting for age, gender, comorbidities, and referral source for admission, patients requiring TTCP had worse survival than those undergoing PPM (n = 17,988) or AICD (n = 5264) implantation, PCI (n = 46,859), or CABG surgery (n = 50,992) (adjusted hazard ratio [aHR]: 2.14, 95% CI 1.94-2.37; aHR: 1.61, 95% CI 1.41-1.83; aHR: 1.76, 95% CI 1.61-1.93; aHR: 2.09, 95% CI 1.98-2.21 respectively, all p < 0.001). CONCLUSION: TTCP utilization is decreasing and is associated with substantial in-hospital and long-term mortality with weekend-weekday variation in outcome. Further studies are needed to develop strategies to better understand the determinants of adverse outcomes of these patients, as well as appropriate strategies for outcome improvement.
BACKGROUND: Temporary-transvenous-cardiac-pacing (TTCP) is a potentially lifesaving procedure, however trends in its utilization and outcomes in unselected contemporary populations are all unknown. METHODS: Consecutive patients requiring TTCP between July-1, 2000 and December-31, 2013 were identified from a statewide registry of admitted patients. In addition, all patients who underwent other cardiac procedures including permanent-pacemaker (PPM) implantation, automated-implantable-cardiac-defibrillator (AICD) implantation, percutaneous-coronary-intervention (PCI), or coronary-artery-bypass-graft (CABG) surgery were identified for comparative outcome analyses. Survival was tracked from a statewide death registry. RESULTS: A total of 4838 patients (mean age [±standard deviation] 74.7 ± 12.7 years; 58.0% males) requiring TTCP were identified. The incidence for TTCP was 5.86 ± 1.06 cases per-100,000-persons-per-annum, declining by 46% between 2003 and 2013. During 4.2 ± 3.7 years of follow-up, 2594 (53.6%) patients died, of whom 569 (11.8%) died during the index admission. Weekend admission was associated with increased mortality compared to weekdays (hazard ratio: 1.15, 95% confidence interval [CI] 1.06-1.26, p = 0.002) and independently predicted all-cause death. After adjusting for age, gender, comorbidities, and referral source for admission, patients requiring TTCP had worse survival than those undergoing PPM (n = 17,988) or AICD (n = 5264) implantation, PCI (n = 46,859), or CABG surgery (n = 50,992) (adjusted hazard ratio [aHR]: 2.14, 95% CI 1.94-2.37; aHR: 1.61, 95% CI 1.41-1.83; aHR: 1.76, 95% CI 1.61-1.93; aHR: 2.09, 95% CI 1.98-2.21 respectively, all p < 0.001). CONCLUSION:TTCP utilization is decreasing and is associated with substantial in-hospital and long-term mortality with weekend-weekday variation in outcome. Further studies are needed to develop strategies to better understand the determinants of adverse outcomes of these patients, as well as appropriate strategies for outcome improvement.
Authors: Christopher C Y Wong; Austin C C Ng; Cuneyt Ada; Vincent Chow; William F Fearon; Martin K C Ng; Leonard Kritharides; Andy S C Yong Journal: PLoS One Date: 2021-12-16 Impact factor: 3.240
Authors: Oholi Tovia-Brodie; Moshe Rav Acha; Bernard Belhassen; Alessio Gasperetti; Marco Schiavone; Giovanni Battista Forleo; Milton E Guevara-Valdivia; David Valdeolivar Ruiz; Nicolas Lellouche; David Hamon; Davide Castagno; Matteo Bellettini; Gaetano M De Ferrari; Mikael Laredo; Jean-Baptiste Carvès; Barbara Ignatiuk; Giampaolo Pasquetto; Paolo De Filippo; Giovanni Malanchini; Behzad B Pavri; Craig Raphael; Luigi Rivetti; Roberto Mantovan; Jason Chinitz; Melissa Harding; Giuseppe Boriani; Edoardo Casali; Elaine Y Wan; Angelo Biviano; Carlos Macias; Stepan Havranek; Pietro Enea Lazzerini; Antonio M Canu; Marco Zardini; Giulio Conte; Óscar Cano; Michela Casella; Boris Rudic; Alexander Omelchenko; Nilesh Mathuria; Gaurav A Upadhyay; Asaf Danon; Arie Lorin Schwartz; Philippe Maury; Shiro Nakahara; Gustavo Goldenberg; Nicolas Schaerli; Sergiy Bereza; Angelo Auricchio; Michael Glikson; Yoav Michowitz Journal: Heart Rhythm Date: 2021-10-26 Impact factor: 6.343
Authors: Maria Hee Jung Park Frausing; Jens Cosedis Nielsen; Jens Brock Johansen; Ole Dan Jørgensen; Thomas Olsen; Christian Gerdes; Jens Kristensen; Mads Brix Kronborg Journal: Heart Rhythm O2 Date: 2021-11-18